We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Bio-Nano-Micro-Informatic Technologies Developed to Help Diagnose DVT and PE

By Labmedica staff writers
Posted on 07 Jan 2008
A European consortium is developing new bio-nano-micro-informatic technologies that will ultimately help clinicians rapidly diagnose patients suspected of deep vein thrombosis (DVT) and pulmonary embolism (PE) at the point-of-first-contact.

Ten European research and high-tech firms are developing a reliable, accurate, mobile, handheld, medical diagnostic prototype device that can be used to rapidly diagnose patients suspected of DVT and PE. More...
Using the latest developments in polymer electronics, biomolecular engineering, lab-on-a-chip, wireless information communications technology (ICT), and nano-bio-technologies, the prototype device will detect D-dimer levels in whole blood. These levels will indicate to healthcare professionals whether they should rule out DVT or refer the patient for further diagnosis. A prototype device will be ready in August of 2009.

The device is expected to improve the speed, accuracy, and reliability with which DVT and related blood clot conditions can be diagnosed at the point-of-first-contact and will enable practitioners to reduce the number of false-positive diagnoses. It will be used at primary point-of-care (POC) locations including hospitals, local clinics, accident and emergency units, doctors' offices, outpatient departments, and by paramedics.

The University of Teesside (Tees Valley, UK) is leading the consortium, which also includes Cenamps (New Castle upon Tyne, UK), Helena Biosciences (Gateshead, UK), Wyeth (Madison, NJ, USA), Fraunhofer Institute (München, Germany), and other companies and universities in Spain, France, Slovakia, and Hungary.


Related Links:
Cenamps
Helena Biosciences
Fraunhofer Institute

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automatic Hematology Analyzer
LABAS F9000
New
PlGF Test
Quidel Triage PlGF Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.